Impact of obesity in patients with urolithiasis and its prognostic usefulness in stone recurrence

被引:95
作者
Lee, Sang-Cheol [1 ]
Kim, Yong-June [1 ]
Kim, Tae-Hwan [2 ]
Yun, Seok-Joong
Lee, Nam Kyu [3 ]
Kim, Wun-Jae [1 ]
机构
[1] Chungbuk Natl Univ, Coll Med, Dept Urol, Cheongju, Chungbuk, South Korea
[2] Kyung Hee Univ, Coll Med, Seoul, South Korea
[3] Soonchunhyang Univ, Coll Med, Cheonan, South Korea
关键词
obesity; urolithiasis; recurrence;
D O I
10.1016/j.juro.2007.09.040
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Purpose: Recent studies have suggested an increased prevalence of urolithiasis and recurrence associated with obesity. We assessed the influence of obesity on stone risk factors as well as on stone recurrence. Materials and Methods: A database of patient history, body mass index, and serum and urine chemistry was analyzed for 704 consecutive stone formers (467 first time stone formers and 247 recurrent stone formers). Obesity was defined as body mass index greater than 25 kg/m(2). The effect of obesity on stone risk factors and recurrence were stratified according to stone episodes. Of these, 163 (23.2%) patients who had been followed for more than 36 months (median 54, range 5 to 148) were included in recurrence analysis. Results: Obesity was significantly associated with stone episodes (p = 0.043). Obese stone formers excreted increased amounts of sodium, calcium, uric acid and citrate, while the urinary pH in a 24-hour urine sample was decreased compared to nonobese stone formers (p < 0.05, respectively). Stone analysis revealed that uric acid stone was significantly more commonly found in the obese patients (p = 0.046). Multivariate Cox regression model stratified by stone episodes revealed that obesity (HR 2.572, 95% CI 1.376-4.807, p = 0.003) was the only strong predictor of stone recurrence in first time stone formers. No association between obesity and stone recurrence was detected in recurrent stone formers. Kaplan-Meier curves showed identical results. Conclusions: This study reveals that obesity is associated with metabolic alterations and urinary stone recurrence. Weight control may be considered one of the preventive modalities against recurrent stone formation, especially in first time stone formers.
引用
收藏
页码:570 / 574
页数:5
相关论文
共 19 条
[1]
Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3
[3]
COE FL, 1974, NEW ENGL J MED, V291, P1344
[4]
Curhan GC, 1998, J AM SOC NEPHROL, V9, P1645
[5]
Deurenberg P, 1998, INT J OBESITY, V22, P1164, DOI 10.1038/sj/ijo/0800741
[6]
Metabolic risk factors and the impact of medical therapy on the management of nephrolithiasis in obese patients [J].
Ekeruo, WO ;
Tan, YH ;
Young, MD ;
Dahm, P ;
Maloney, ME ;
Mathias, BJ ;
Albala, DM ;
Preminger, GM .
JOURNAL OF UROLOGY, 2004, 172 (01) :159-163
[7]
Metabolic syndrome and development of diabetes mellitus: Application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study [J].
Laaksonen, DE ;
Lakka, HM ;
Niskanen, LK ;
Kaplan, GA ;
Salonen, JT ;
Lakka, TA .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 156 (11) :1070-1077
[8]
The efficacy of potassium citrate based medical prophylaxis for preventing upper urinary tract calculi: A midterm followup study [J].
Lee, YH ;
Huang, WC ;
Tsai, JY ;
Huang, JK .
JOURNAL OF UROLOGY, 1999, 161 (05) :1453-1457
[9]
Metabolic evaluation of stone disease patients: A practical approach [J].
Lifshitz, DA ;
Shalhav, AL ;
Lingeman, JE ;
Evan, AP .
JOURNAL OF ENDOUROLOGY, 1999, 13 (09) :669-678
[10]
Medical reduction of stone risk in a network of treatment centers compared to a research clinic [J].
Lingeman, J ;
Mardis, H ;
Kahnoski, R ;
Goldfarb, DS ;
Lacy, S ;
Grasso, M ;
Scheinman, SJ ;
Parks, JH ;
Asplin, JR ;
Coe, FL .
JOURNAL OF UROLOGY, 1998, 160 (05) :1629-1634